Avacta Group Plc
| London Stock Exchange: AVCT
Avacta Group Plc engages in the business of healthcare technology and consumables. It provides innovative and proprietary solutions to the life sciences and healthcare sector. The company operates through two segments: Analytical and Animal Health. The Analytical segment provides high-end analytical instrumentation and services to the biopharmaceutical sector, which includes the provision of tools and contract services for early stage protein characterisation and analysis for biopharmaceutical drug developers. The Animal Health segment engages in providing diagnostic products and services for global veterinary diagnostics market, which includes the provision of tools and contract services to assist diagnosis of conditions in animals to enable faster treatment for veterinarians. Avacta Group was founded by Alastair MacLaughlin Smith, Simon Webster and Kurt Justin Baldwin in January 2004 and is headquartered in Leeds, the United Kingdom.